GlassScriptPhysician profile
Frank W Ling
NPI 1720003155
$1,682.64
in general payments reported to CMS, 2019-2025
20 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.47 · 2020: $164 · 2021: $256 · 2022: $132 · 2023: $617 · 2024: $212 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $775 · Education: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $775.08 |
| Education | $298.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $552.23 | 2019-2025 | Veozah |
| Abbvie INC. | $317.05 | 2019-2023 | |
| Hologic Sales and Service, LLC | $168.37 | 2019-2025 | Myosure Tissue Removal Device, Aptima, Novasure |
| Sumitomo Pharma America, INC. | $112.60 | 2023-2025 | Gemtesa, Myfembree |
| Coopersurgical, INC. | $95.94 | 2024-2025 | Sos, Summit Doppler, Paragard T 380a |
| Pfizer INC. | $83.79 | 2023-2025 | |
| Biogen, INC. | $54.11 | 2024-2025 | Zurzuvae |
| Axonics, INC. | $50.22 | 2021-2023 | Bulkamid |
| Avion Pharmaceuticals | $46.13 | 2020-2022 | |
| Channel Medsystems, INC. | $39.31 | 2024 | |
| Aspira Women'S Health INC | $29.55 | 2021 | |
| Organon LLC | $24.00 | 2022 | |
| Collegium Pharmaceutical, INC. | $15.37 | 2021 | |
| Laborie Medical Technologies Corp. | $14.85 | 2020 | |
| Scynexis, INC. | $14.39 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.38 | 2020 | |
| Mylan Pharmaceuticals INC. | $13.28 | 2021 | |
| Vertical Pharmaceuticals, LLC | $12.90 | 2020 | |
| Urovant Sciences INC | $12.16 | 2022 | |
| Lupin INC. | $12.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Ling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.